Chancery Stays Suit Over Drug Trial Disclosure Failures
Stockholders who sued a biotech company for alleged failures to disclose bad news about drug trials for the company's lone product in 2017 have had their Delaware Chancery Court case put...To view the full article, register now.
Already a subscriber? Click here to view full article